FOR PATIENTS · SOURCE READING
Hydatidiform Moles
Source: Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 25, 2022 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Options for Gestational Trophoblastic Disease
Treatment of a hydatidiform mole may include the following:
Source links and citations
Surgery (Dilatation and curettage with suction evacuation) to remove the tumor.
Source links and citations
After surgery, beta human chorionic gonadotropin (beta-hCG) blood tests are done every week until the beta-hCG level returns to normal. Patients also have follow-up doctor visits monthly for up to 6 months. If the level of beta-hCG does not return to normal or increases, it may mean the hydatidiform mole was not completely removed and it has become cancer. Pregnancy causes beta-hCG levels to increase, so your doctor will ask you not to become pregnant until follow-up is finished.
Source links and citations
For disease that remains after surgery, treatment is usually chemotherapy.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle